♟️ Wednesday 29 January 2025 Wed, 29 Jan 2025

Astute Metals reports breakthrough lithium mineralisation at its Red Mountain Project in Nevada, with new high-grade zones and exceptional metallurgical leachability results paving the way for a maiden resource in 2025.

Astute Metals NL secures $1.92 million through a share placement to advance its Red Mountain Lithium Project in Nevada, while launching a Loyalty Option Plan to reward shareholders.

Trek Metals has reported impressive high-grade gold intercepts at its Christmas Creek Project in Western Australia, signaling the potential for a significant orogenic gold system. The company is advancing its exploration with refined drilling targets and ongoing work at its McEwen Hills Niobium Project.

Gateway Mining Ltd has fortified its balance sheet through the sale of its Eastern Montague Gold Project, positioning itself for an aggressive exploration campaign in 2025 focused on the Barrelmaker Gold and Montague Range Base Metals projects in Western Australia.

Lycaon Resources has addressed an ASX price query, confirming no undisclosed information influenced recent trading and releasing assay results from its Stansmore Project drilling program.

Critical Minerals Group (CMG) has secured a $2.7 million federal grant to fast-track its vanadium electrolyte manufacturing facility in Queensland, alongside key project milestones and strategic leadership appointments.

Surefire Resources NL has announced a significant extension of gold mineralisation at its Yidby Gold Project, now exceeding 500 metres in strike length. The company’s recent drilling and metallurgical test work support plans for a low-cost heap leach operation.

Austral Resources Australia Ltd reports steady operational progress and promising resource developments in its December 2024 quarter, while navigating an ongoing recapitalisation and leadership transition.

PVW Resources has appointed Lucas Stanfield as CEO, bringing rare earths project expertise to accelerate development of its Brazilian assets. Stanfield’s leadership marks a strategic pivot towards advancing critical mineral projects in a globally significant mining jurisdiction.

PhosCo has achieved critical milestones with the approval of its Gassaat Phosphate Project and a strategic MoU with the Tunisian Government and EBRD, setting the stage for a major drilling campaign and positioning itself as a future global fertilizer supplier.

Boss Energy has declared commercial production effective January 1, 2025, reporting strong quarterly uranium output growth and a robust financial position. The company remains on track to deliver 850,000 pounds of U3O8 in FY2025 amid ongoing ramp-up and expansion initiatives.

Lucapa Diamond Company reports a 5% increase in diamond production at Lulo alongside a strategic restart plan and compelling base metals discoveries at its Merlin project, supported by a recent capital raise and leadership change.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.

Skylark Minerals has reshaped its leadership team with seasoned gold industry veterans and agreed to divest its Citronen Zn-Pb Project, positioning the company for renewed growth and exploration success.

Brazilian Rare Earths Limited reports unprecedented ultra-high-grade rare earth intercepts and significant district-scale mineral discoveries at its Monte Alto project, alongside key permitting milestones advancing its mining ambitions.

Global Lithium Resources pauses Definitive Feasibility Study on its flagship Manna Lithium Project due to challenging lithium markets, while advancing strategic acquisitions and exploration in Western Australia.

Alpha HPA Limited has reached a major funding milestone with a $400 million senior debt package for its HPA First Project Stage 2, while experiencing accelerating demand from the semiconductor sector and advancing new product developments.

Neurotech International reports key clinical progress in paediatric neurological disorders, securing FDA orphan drug designation for its Rett Syndrome treatment and advancing pivotal trials for ASD and PANDAS/PANS.

Rox Resources has completed its $27 million capital raising with the final tranche of shares issued to institutional investors and company directors, signaling strong backing for its growth plans.

American Rare Earths has expanded its Halleck Creek Rare Earth Project resource by 12.2% to 2.63 billion tonnes with improved grades, reinforcing its role in securing U.S. critical mineral independence.

PYC Therapeutics reports substantial progress across all four of its drug development programs in Q4 2024, including key regulatory designations and clinical milestones that set the stage for pivotal trials in 2025.

Neurizon Therapeutics reports encouraging 8-month interim results for its ALS drug NUZ-001, secures Orphan Medicinal Product Designation in Europe, and raises $885,000 through a share placement, maintaining a robust $14 million cash position.

Infinity Lithium reports steady progress on its San José Lithium Project with updated mining licence requirements and a strategic pivot to new European funding opportunities.

Holista Colltech Limited reports a notable financial recovery in 4QFY24, underpinned by strong cash inflows and a rebound in its Food Ingredients division, alongside a leadership change aimed at steering future growth.